FR2349600A1 - Nouveaux adjuvants immunologiques - Google Patents

Nouveaux adjuvants immunologiques

Info

Publication number
FR2349600A1
FR2349600A1 FR7712319A FR7712319A FR2349600A1 FR 2349600 A1 FR2349600 A1 FR 2349600A1 FR 7712319 A FR7712319 A FR 7712319A FR 7712319 A FR7712319 A FR 7712319A FR 2349600 A1 FR2349600 A1 FR 2349600A1
Authority
FR
France
Prior art keywords
immunological adjuvants
new immunological
new
adjuvants
immunological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7712319A
Other languages
English (en)
French (fr)
Other versions
FR2349600B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/680,260 external-priority patent/US4082735A/en
Priority claimed from US05/680,618 external-priority patent/US4082736A/en
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of FR2349600A1 publication Critical patent/FR2349600A1/fr
Application granted granted Critical
Publication of FR2349600B1 publication Critical patent/FR2349600B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7712319A 1976-04-26 1977-04-22 Nouveaux adjuvants immunologiques Granted FR2349600A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/680,260 US4082735A (en) 1976-04-26 1976-04-26 Novel immunological adjuvant compounds and methods of preparation thereof
US05/680,618 US4082736A (en) 1976-04-26 1976-04-26 Novel immunological adjuvant compounds and methods of preparation thereof
US77720477A 1977-03-14 1977-03-14

Publications (2)

Publication Number Publication Date
FR2349600A1 true FR2349600A1 (fr) 1977-11-25
FR2349600B1 FR2349600B1 (de) 1981-01-02

Family

ID=27418368

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7712319A Granted FR2349600A1 (fr) 1976-04-26 1977-04-22 Nouveaux adjuvants immunologiques

Country Status (8)

Country Link
JP (2) JPS52131526A (de)
CH (1) CH636887A5 (de)
DE (1) DE2718010A1 (de)
ES (1) ES458197A1 (de)
FR (1) FR2349600A1 (de)
GB (1) GB1571133A (de)
NL (1) NL7704555A (de)
SE (1) SE445924B (de)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002677A1 (de) * 1977-12-02 1979-07-11 Takeda Chemical Industries, Ltd. Glucosamin-peptid-Derivate und ihre pharmazeutischen Zusammensetzungen
EP0004512A1 (de) * 1978-03-20 1979-10-03 ANVAR Agence Nationale de Valorisation de la Recherche Muramyl-Peptide-Ester-Derivate und ihre Verwendung in pharmazeutischen Zusammensetzungen und Laboratorium-Reagenzien
WO1979000802A1 (fr) * 1978-03-20 1979-10-18 Anvar Nouveaux composes esters de muramyl-peptide et leurs applications dans les compositions pharmaceutiques et reactifs de laboratoire
EP0014159A1 (de) * 1979-01-29 1980-08-06 Merck & Co. Inc. Immunologisch aktive Dipeptidyl-Saccharide und Verfahren zur Herstellung
EP0015810A1 (de) * 1979-02-20 1980-09-17 ANVAR Agence Nationale de Valorisation de la Recherche N-Acetyl-L-(N-methyl-alanyl)-D-isoglutamin sowie Gemische, die diese Verbindung enthalten, zur Regulierung der Immunreaktionen
EP0015468A1 (de) * 1979-02-28 1980-09-17 Takeda Chemical Industries, Ltd. 6-Deoxyglucosamin-Peptid-Derivate, ihre Herstellung und Verwendung
FR2482957A2 (fr) * 1979-06-29 1981-11-27 Rhone Poulenc Ind Nouveaux dipeptides, leur preparation et les medicaments qui les contiennent
EP0013856B1 (de) * 1978-12-22 1983-03-09 ANVAR Agence Nationale de Valorisation de la Recherche Verbindungen welche Peptidyl- oder Aminoacylreste mit lipophilen Gruppen verbinden und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
JPS6042398A (ja) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka ムラミルジペプチド活性エステル誘導体
US4777160A (en) * 1986-09-18 1988-10-11 Bristol-Myers BU-2867T peptide antibiotics
US10927147B2 (en) 2015-12-10 2021-02-23 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
US10576147B2 (en) 2015-12-15 2020-03-03 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002677A1 (de) * 1977-12-02 1979-07-11 Takeda Chemical Industries, Ltd. Glucosamin-peptid-Derivate und ihre pharmazeutischen Zusammensetzungen
EP0004512A1 (de) * 1978-03-20 1979-10-03 ANVAR Agence Nationale de Valorisation de la Recherche Muramyl-Peptide-Ester-Derivate und ihre Verwendung in pharmazeutischen Zusammensetzungen und Laboratorium-Reagenzien
WO1979000802A1 (fr) * 1978-03-20 1979-10-18 Anvar Nouveaux composes esters de muramyl-peptide et leurs applications dans les compositions pharmaceutiques et reactifs de laboratoire
EP0013856B1 (de) * 1978-12-22 1983-03-09 ANVAR Agence Nationale de Valorisation de la Recherche Verbindungen welche Peptidyl- oder Aminoacylreste mit lipophilen Gruppen verbinden und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
EP0014159A1 (de) * 1979-01-29 1980-08-06 Merck & Co. Inc. Immunologisch aktive Dipeptidyl-Saccharide und Verfahren zur Herstellung
EP0015810A1 (de) * 1979-02-20 1980-09-17 ANVAR Agence Nationale de Valorisation de la Recherche N-Acetyl-L-(N-methyl-alanyl)-D-isoglutamin sowie Gemische, die diese Verbindung enthalten, zur Regulierung der Immunreaktionen
FR2449697A1 (fr) * 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
EP0015468A1 (de) * 1979-02-28 1980-09-17 Takeda Chemical Industries, Ltd. 6-Deoxyglucosamin-Peptid-Derivate, ihre Herstellung und Verwendung
FR2482957A2 (fr) * 1979-06-29 1981-11-27 Rhone Poulenc Ind Nouveaux dipeptides, leur preparation et les medicaments qui les contiennent

Also Published As

Publication number Publication date
GB1571133A (en) 1980-07-09
NL7704555A (nl) 1977-10-28
SE445924B (sv) 1986-07-28
DE2718010A1 (de) 1977-11-10
SE7704609L (sv) 1977-10-27
JPH0371440B2 (de) 1991-11-13
JPH02138290A (ja) 1990-05-28
JPS638119B2 (de) 1988-02-19
JPS52131526A (en) 1977-11-04
CH636887A5 (en) 1983-06-30
FR2349600B1 (de) 1981-01-02
DE2718010C2 (de) 1990-11-08
ES458197A1 (es) 1978-08-16

Similar Documents

Publication Publication Date Title
BE852223A (fr) Nouveaux aminoalcoylheterocycles
SE433419B (sv) Synkronmotor
DK145813C (da) Formbevarende engangsble
IT1087285B (it) Procedimento di determinazione immunologico
FR2351283A1 (fr) Cryopompe
FR2346346A1 (fr) Nouveaux amino-chromanols
DK147116C (da) Motorkompressor
SE7614142L (sv) Kompressor
FR2349600A1 (fr) Nouveaux adjuvants immunologiques
IT1086291B (it) Struttura di carburatore
AR214749A1 (es) Carburador
IT1074388B (it) Compressore centrifugo
SE7710710L (sv) Immunologiskt bestemningsforfarande
AT352035B (de) Magnetscheider
BR7707103A (pt) Separador magnetico
DK510977A (da) Hygiejnisk-kosmetisk praeparat
DK429077A (da) Stykformet rensemiddel
BR7701835A (pt) Separador magnetico
BE852955A (fr) Nouveaux amino-chromanols
BE855993A (fr) Presseur
SE7612599L (sv) Avskiljare
SE418004B (sv) Centrifugalpump
FR2340937A1 (fr) Nouveaux composes anti-hypertensifs
BE861983A (fr) Nouveaux d-homosteroides
BE853313A (fr) Nouveaux omega-amino-alcoxylcanes